Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eisai Explores New Business Model

This article was originally published in The Pink Sheet Daily

Executive Summary

Facing stronger global competition and a patent cliff for Alzheimer’s standard Aricept, Tokyo company moves to patient-centered model, proposes special communities for dementia patients.

You may also be interested in...



Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide

TOKYO - Eisai CEO Haruo Naito unveiled plans to revamp the company's research and development structure in hopes of having his employees produce better results, Naito told analysts Feb. 27 in Tokyo

More Reform Eyed For Japan's OTC Deregulation

Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products

More Reform Eyed For Japan's OTC Deregulation

Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products

Topics

UsernamePublicRestriction

Register

PS069128

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel